Company / Cash per Share
Apogee Therapeutics, Inc. Cash per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.57
FY2024
5-year range
$2.57 / $61.69
FY2022-FY2024
Trend
-45.7%
vs FY2023
Sector context
#84 of 205
Health Care
What the data says
At $2.57, Apogee Therapeutics, Inc.'s cash per share ranks #84 of 205 in the Health Care sector. Declined from $61.69 to $2.57 over the past 2 years.
Based on SEC 10-K filings.
2.57 in FY2024.
Declined from $61.69 to $2.57 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 205 in Health CareTop 41% of 205This company $2.57 Sector average $72.93
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2024, cash per share decreased 45.7% year-over-year.
- Ranks #84 out of 205 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.57 | -45.7% |
| FY2023 | $4.73 | -92.3% |
| FY2022 | $61.69 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026